知镜 Cognispect · 医学文献与研究工作台

Low-Density Lipoprotein Cholesterol Goal Attainment in Indian Patients With Coronary Artery Disease: A Nationwide Study.

Puri R, Bansal M, Mahajan K, Gupta R, Mehta V, Iyengar SS, Prabhakar D, Agarwala R, Khan A, Bordoloi N, Desai N, George S, Majumder B, Shrivastava S, Vijan V, Mahilmaran A, Jain D, Shetty SR, Duell PB, Wong ND, LAI-LCARE Study Investigators.
JACC. Asia · 2026-06-29 · PMID 42376721

文献摘要

Background Premature atherosclerotic cardiovascular disease (ASCVD) remains a significant challenge in India, despite comparatively lower population-level low-density lipoprotein cholesterol (LDL-C) levels. The Lipid Association of India advocates for aggressive lipid-lowering therapy to achieve an LDL-C target Objectives This study aimed to provide contemporary data on LDL-C goal attainment in Indian patients with ASCVD. Methods In this largest Indian study to date, 122 cardiologists across India recruited 10,417 patients (9,658 included in analysis, mean age 60.7 ± 11.0 years, 7,427 [76.9%] men) with documented coronary artery disease who were on stable lipid-lowering therapy for at least 1 month before their most recent LDL-C measurement. Only directly measured LDL-C was considered. Results The median treated LDL-C concentration was 66.1 mg/dL (IQR: 49.0-92.0) with only 27.0% (2,603 of 9,658, 95% CI: 26.1%-27.8%) having values ≤50 mg/dL. High-intensity statin therapy was used in 73.3% (7,047/9,615, 95% CI: 72.4%-74.2%) of subjects. Combination LDL-C lowering therapy was used in 11.9% (1,153/9,658, 95% CI: 11.3%-12.6%) of subjects [8.6% (830/9,658, 95% CI: 8.0%-9.2%) receiving two drugs, 3.3% (323/9,658, 95% CI: 3.0%-3.7%) receiving 3 drugs]. Among patients with LDL-C >50 mg/dL, the treating clinicians uptitrated the regimen in only 37.3% (2,552 of 6,833, 95% CI: 36.2%-38.5%) of subjects. Conclusions This study highlights a major gap in LDL-C control for secondary prevention of ASCVD in India. Despite high-intensity statin use, only one-quarter achieved target levels. The low utilization of combination therapy and the limited treatment intensification observed in patients with LDL-C above target represent important opportunities for improving lipid management and cardiovascular outcomes.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。